Anum Saeed1,2, Kaustubh Dabhadkar3, Salim S Virani1,2,4,5,6, Peter H Jones2, Christie M Ballantyne1,2,7, Vijay Nambi8,9,10,11. 1. Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. 2. Center for Cardiometabolic Disease Prevention, Baylor College of Medicine, Houston, TX, USA. 3. Division of Cardiology, Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA. 4. Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. 5. Health Policy, Quality and Informatics Program, Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations, Houston, TX, USA. 6. The Aga Khan University, Karachi, Pakistan. 7. Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. 8. Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. vnambi@bcm.edu. 9. Center for Cardiometabolic Disease Prevention, Baylor College of Medicine, Houston, TX, USA. vnambi@bcm.edu. 10. Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. vnambi@bcm.edu. 11. , 6655 Travis Street, Suite 320, Houston, TX, 77030, USA. vnambi@bcm.edu.
Abstract
PURPOSE: Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide, necessitating major efforts in prevention. This review summarizes the currently available training opportunities in CVD prevention for fellows-in-training (FITs) and residents. We also highlight the challenges and future directions for CVD prevention as a field and propose a structure for an inclusive CVD prevention training program. RECENT FINDINGS: At present, there is a lack of centralized training resources for FITs and residents interested in pursuing a career in CVD prevention. Training in CVD prevention is not an accredited subspecialty fellowship by the American Council of Graduate Medical Education (ACGME). Although there are several independent training programs under the broad umbrella of CVD prevention focusing on different aspects of prevention, there is no unified curriculum or training. More collaborative efforts are needed to identify CVD prevention as an ACGME-accredited subspecialty fellowship. Providing more resources can encourage and produce more leaders in this essential field.
PURPOSE:Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide, necessitating major efforts in prevention. This review summarizes the currently available training opportunities in CVD prevention for fellows-in-training (FITs) and residents. We also highlight the challenges and future directions for CVD prevention as a field and propose a structure for an inclusive CVD prevention training program. RECENT FINDINGS: At present, there is a lack of centralized training resources for FITs and residents interested in pursuing a career in CVD prevention. Training in CVD prevention is not an accredited subspecialty fellowship by the American Council of Graduate Medical Education (ACGME). Although there are several independent training programs under the broad umbrella of CVD prevention focusing on different aspects of prevention, there is no unified curriculum or training. More collaborative efforts are needed to identify CVD prevention as an ACGME-accredited subspecialty fellowship. Providing more resources can encourage and produce more leaders in this essential field.
Entities:
Keywords:
CVD prevention training; Cardiology training programs; Fellows-in-training; Fellowship; Heart disease prevention; Preventive cardiology training
Authors: Sidney C Smith; Vera Bittner; J Michael Gaziano; John C Giacomini; Quinn R Pack; Donna M Polk; Neil J Stone; Stanley Wang Journal: J Am Coll Cardiol Date: 2015-03-13 Impact factor: 24.094
Authors: Donald M Lloyd-Jones; Pamela B Morris; Christie M Ballantyne; Kim K Birtcher; David D Daly; Sondra M DePalma; Margo B Minissian; Carl E Orringer; Sidney C Smith Journal: J Am Coll Cardiol Date: 2016-04-01 Impact factor: 24.094
Authors: Paul S Jellinger; Yehuda Handelsman; Paul D Rosenblit; Zachary T Bloomgarden; Vivian A Fonseca; Alan J Garber; George Grunberger; Chris K Guerin; David S H Bell; Jeffrey I Mechanick; Rachel Pessah-Pollack; Kathleen Wyne; Donald Smith; Eliot A Brinton; Sergio Fazio; Michael Davidson Journal: Endocr Pract Date: 2017-04 Impact factor: 3.443
Authors: Terry A Jacobson; Matthew K Ito; Kevin C Maki; Carl E Orringer; Harold E Bays; Peter H Jones; James M McKenney; Scott M Grundy; Edward A Gill; Robert A Wild; Don P Wilson; W Virgil Brown Journal: J Clin Lipidol Date: 2015-04-07 Impact factor: 4.766
Authors: Leticia Fernández-Friera; Valentín Fuster; Beatriz López-Melgar; Belén Oliva; José M García-Ruiz; José Mendiguren; Héctor Bueno; Stuart Pocock; Borja Ibáñez; Antonio Fernández-Ortiz; Javier Sanz Journal: J Am Coll Cardiol Date: 2017-12-19 Impact factor: 24.094
Authors: Vijay Nambi; Xiaoxi Liu; Lloyd E Chambless; James A de Lemos; Salim S Virani; Sunil Agarwal; Eric Boerwinkle; Ron C Hoogeveen; David Aguilar; Brad C Astor; Pothur R Srinivas; Anita Deswal; Thomas H Mosley; Josef Coresh; Aaron R Folsom; Gerardo Heiss; Christie M Ballantyne Journal: Clin Chem Date: 2013-09-13 Impact factor: 8.327